as on February 5, 2026 at 11:41 pm IST
Day's Low
Day's High
2.43%
Downside
4.04%
Upside
52 Week's Low
52 Week's High
40.70%
Downside
66.04%
Upside
Check Orchestra Biomed Holdings Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$223.0M
EPS (TTM)
-1.739
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0PEG Ratio
0EBITDA
-74.9M
Revenue (TTM)
2.8M
Profit Margin
0.00%
Return On Equity TTM
-166.97%
Compare market cap, revenue, PE, and other key metrics of Orchestra Biomed Holdings Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $223.0M | NA | NA | 0.00% | |
| BUY | $122.3B | 118.58% | 33.56 | 31.35% | |
| BUY | $47.7B | 113.17% | 1246.03 | 1.36% | |
| NA | $37.4B | NA | 662.33 | 1.38% | |
| BUY | $80.8B | 55.33% | 18.28 | 32.13% |
The Orchestra Biomed Holdings Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Orchestra Biomed Holdings Inc investment value today
Current value as on today
₹65,409
Returns
Returns from Orchestra Biomed Holdings Inc Stock
Dollar Returns*
₹3,368 (+3.37%)
Based on 9 analysts
88.89%
Buy
11.11%
Hold
0.00%
Sell
Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Orchestra Biomed Holdings Inc. Average target price of $13.43
Get share price movements and forecasts by analysts on Orchestra Biomed Holdings Inc.
What analysts predicted
72.38%UPSIDE
Target Price
$13.43
Current Price
$3.71
Analyzed by
9 Analysts
Target
$13.43
Orchestra Biomed Holdings Inc target price $13.43, a slight upside of 72.38% compared to current price of $3.71. According to 9 analysts rating.
Search interest for Orchestra Biomed Holdings Inc Stock has increased by 400% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:400% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 11 November
Tue, 03:38 PM
-Orchestra BioMed reports Q3 EPS of 40c, below consensus of 43c, but revenue exceeds expectations at $861,000.
Tue, 07:30 PM
-Orchestra BioMed announces participation in upcoming investor conferences, including Jefferies and Piper Healthcare Conferences.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 836.0K → 861.0K (in $), with an average increase of 2.9% per quarter
Price Rise
![]()
In the last 6 months, OBIO stock has moved up by 42.3%
Against Peers
![]()
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 37.0% return, outperforming this stock by 94.6%
Against Peers
![]()
In the last 1 year, Beone Medicines Ltd has given 54.6% return, outperforming this stock by 91.1%
Profit Down
![]()
Netprofit is down for the last 5 quarters, -15.42M → -20.82M (in $), with an average decrease of 7.9% per quarter
| Organisation | Orchestra Biomed Holdings Inc |
| Headquarters | 150 Union Square Drive, New Hope, PA, United States, 18938 |
| CEO | Mr. David P. Hochman |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Darren R. Sherman | Founder, President, COO & Director |
Mr. William Reed Little | Executive Vice President of Corporate Development & Strategy |
Dr. Hans-Peter Stoll M.D., Ph.D. | Senior VP & Medical Director |
Dr. Avraham Matityahu Fischer M.D. | Senior Vice President of Medical Affairs & Innovation |
Mr. Juan Lorenzo | Senior Vice President of Product Development |
Mr. David P. Hochman | Founder, Chairman of the Board of Directors & CEO |
Mr. Andrew Lawrence Taylor M.B.A. | Chief Financial Officer |
Ms. Lisa Daniels | Vice President of Human Resources |
Dr. Yuval Hay Mika D.Sc, Ph.D. | GM & CTO of Bioelectronic Therapies |
Mr. Bob Laughner | Senior Vice President of Regulatory & Quality |
Orchestra Biomed Holdings Inc share price today is $3.71 as on . Orchestra Biomed Holdings Inc share today touched a day high of $3.86 and a low of $3.62.
Orchestra Biomed Holdings Inc share touched a 52 week high of $6.16 on and a 52 week low of $2.2 on . Orchestra Biomed Holdings Inc stock price today i.e. is trending at $3.71,which is 39.77% down from its 52 week high and 68.64% up from its 52 week low.
Orchestra Biomed Holdings Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Orchestra Biomed Holdings Inc (OBIO) shares with as little as ₹90.283 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹902.83 in Orchestra Biomed Holdings Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Orchestra Biomed Holdings Inc share’s latest price of $3.71 as on February 5, 2026 at 11:41 pm IST, you will get 2.6954 shares of Orchestra Biomed Holdings Inc. Learn more about
fractional shares .